KCNG1 Gene

Migration, Crosslink

📖

KCNG1 Gene

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-kcng1

📖 Wiki Page

gene1357 wordssynced 2026-04-02

KCNG1 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNG1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNG1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Voltage-Gated Channel Modulator Subfamily G Member 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5q31.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>27040</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000001751</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9UQB8 (Kv6.1)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Voltage-gated potassium channel, modulatory subunit</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Partner Channels</td>
</tr>
<tr>
<td class="label">Kv6.1 (KCNG1)</td>
<td>Kv2.1, Kv2.2</td>
</tr>
<tr>
<td class="label">Kv6.2 (KCNG2)</td>
<td>Kv2.1</td>
</tr>
<tr>
<td class="label">Kv6.3 (KCNG3)</td>
<td>Kv2.1, Kv1.x</td>
</tr>
<tr>
<td class="label">Kv6.4 (KCNG4)</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Kv Channel Changes</td>
</tr>
<tr>
<td class="label">AD</td>
<td>Kv2.1 downregulation</td>
</tr>
<tr>
<td class="label">PD</td>
<td>Altered Kv1.x expression</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Kv channel reduction</td>
</tr>
<tr>
<td class="label">HD</td>
<td>Kv1.1, Kv1.2 changes</td>
</tr>
<tr>
<td class="lab

...

KCNG1 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNG1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNG1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Voltage-Gated Channel Modulator Subfamily G Member 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5q31.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>27040</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000001751</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9UQB8 (Kv6.1)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Voltage-gated potassium channel, modulatory subunit</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Partner Channels</td>
</tr>
<tr>
<td class="label">Kv6.1 (KCNG1)</td>
<td>Kv2.1, Kv2.2</td>
</tr>
<tr>
<td class="label">Kv6.2 (KCNG2)</td>
<td>Kv2.1</td>
</tr>
<tr>
<td class="label">Kv6.3 (KCNG3)</td>
<td>Kv2.1, Kv1.x</td>
</tr>
<tr>
<td class="label">Kv6.4 (KCNG4)</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Kv Channel Changes</td>
</tr>
<tr>
<td class="label">AD</td>
<td>Kv2.1 downregulation</td>
</tr>
<tr>
<td class="label">PD</td>
<td>Altered Kv1.x expression</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Kv channel reduction</td>
</tr>
<tr>
<td class="label">HD</td>
<td>Kv1.1, Kv1.2 changes</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

KCNG1 (Potassium Voltage-Gated Channel Modulator Subfamily G Member 1) encodes Kv6.1, a modulatory subunit of voltage-gated potassium channels. While not traditionally classified as a primary neurodegenerative disease gene, KCNG1 and related Kv channel modulators play important roles in neuronal excitability, synaptic transmission, and cellular responses to metabolic stress—processes central to [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)[@kramer2000][@murakoshi1999][@rudy2001].

Gene Information

Protein Structure and Function

Kv Channel Architecture

Voltage-gated potassium (Kv) channels are tetrameric assemblies of pore-forming alpha subunits[@kramer2000][@murakoshi1999]. While some Kv alpha subunits can form functional homomeric channels, the Kv6, Kv7, Kv8, and Kv9 subfamilies (the silent subunits) lack functional channel activity when expressed alone and instead modulate the function of other Kv channels[@kramer2000][@murakoshi1999].

Kv6.1 Structure

KCNG1 encodes Kv6.1, which contains:

Six transmembrane segments (S1-S6): Standard Kv channel topology
Voltage-sensing domain (S1-S4): Non-functional in Kv6.1 (does not couple to gating)
Pore domain (S5-S6): Does not form conducting pore on its own
Cytoplasmic N- and C-termini: Contain regulatory domains for modulation[@kramer2000][@murakoshi1999]

The key feature distinguishing Kv6.1 from canonical Kv channels is its inability to form functional homomeric channels—instead, it co-assembles with other Kv alpha subunits to modify their properties[@kramer2000][@murakoshi1999].

Modulatory Mechanisms

Kv6.1 modulates neuronal potassium currents through several mechanisms[@kramer2000][@murakoshi1999][@rudy2001]:

Co-assembly with Kv2.1: Kv6.1 potently modulates Kv2.1 channels, one of the major delayed-rectifier K+ currents in [neurons](/entities/neurons)[@kramer2000][@murakoshi1999]

Altered trafficking: Kv6.1 can affect the surface expression of partner channels

Modified gating: Changes in activation/inactivation kinetics of the partner channel

Altered pharmacological sensitivity: Modifies drug binding and sensitivity[@kramer2000][@murakoshi1999]

Expression Pattern

KCNG1 exhibits tissue-specific expression[@kramer2000][@murakoshi1999]:

Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum
Heart: Moderate expression in cardiac tissue
Skeletal muscle: Lower expression
Pancreas: Detectable expression

In the brain, Kv6.1 expression is particularly prominent in regions vulnerable to neurodegeneration, including the hippocampus and basal ganglia[@kramer2000][@murakoshi1999].

Role in Neurodegeneration

Alzheimer's Disease

Research has implicated potassium channel dysfunction in AD pathophysiology[@murakoshi1999][@rudy2001][@ye2019]:

[Amyloid-beta](/proteins/amyloid-beta) effects: A-beta exposure alters Kv channel expression and function in neurons
Neuronal excitability: A-beta-induced hyperexcitability involves potassium current modifications
Calcium dysregulation: Kv channel dysfunction contributes to intracellular calcium overload
Synaptic dysfunction: Potassium channel changes contribute to synaptic failure[@murakoshi1999][@rudy2001][@ye2019]

Kv6.1 modulation of Kv2.1 may be particularly relevant, as Kv2.1 dysfunction has been documented in AD models[@murakoshi1999][@rudy2001].

Parkinson's Disease

Dopaminergic neuron vulnerability: Kv channel dysfunction contributes to PD-related dopaminergic neuron loss
Motor neuron excitability: Altered potassium currents in PD models
Neuroprotection targets: Potassium channel modulators are being explored as neuroprotective strategies[@rudy2001][@barrese2018]

Amyotrophic Lateral Sclerosis

Motor neuron hyperexcitability: ALS is associated with hyperexcitability that may involve potassium channel alterations
Kv channel changes: Studies show altered Kv channel expression in ALS motor neurons
Therapeutic targeting: Potassium channel modulators may reduce excitotoxicity[@rudy2001][@kuo2005]

Ischemia and Stroke

Ischemic tolerance: Kv channels are involved in neuronal responses to metabolic stress
Preconditioning: Kv channel modulators can induce protective responses
[Blood-brain barrier](/entities/blood-brain-barrier): Kv channels affect cerebral vascular function[@rudy2001][@yu2003]

Molecular Mechanisms

Neuronal Excitability Regulation

Kv6.1 modulation of Kv2.1 affects neuronal firing patterns[@kramer2000][@murakoshi1999]:

Delayed rectifier current (IK): Kv2.1 contributes to the major delayed rectifier current
Action potential repolarization: Proper K+ efflux is essential for repolarization
Frequency coding: Kv channel properties affect firing frequency and pattern
Afterhyperpolarization: K+ currents shape afterhyperpolarization[@kramer2000][@murakoshi1999]

Metabolic Stress Response

Kv channels, including Kv6.1-modulated channels, respond to metabolic stress[@murakoshi1999][@rudy2001][@yu2003]:

ATP-sensitive mechanisms: KCNG1 expression can be modulated by cellular energy status
Oxidative stress: [Reactive oxygen species](/entities/reactive-oxygen-species) affect Kv channel function
Calcium signaling: Kv channels interact with calcium signaling pathways
[Apoptosis](/entities/apoptosis): K+ channel changes are early events in apoptotic cascades[@murakoshi1999][@rudy2001]

Synaptic Plasticity

Kv channels modulate synaptic transmission and plasticity[@kramer2000][@murakoshi1999]:

Presynaptic terminals: Kv channel function affects neurotransmitter release
Postsynaptic integration: Dendritic Kv currents affect synaptic integration
[Long-term potentiation](/mechanisms/long-term-potentiation): Kv channel modifications alter LTP induction
Learning and memory: Kv channel function is essential for cognitive processes[@kramer2000][@murakoshi1999]

Kv Channel Subunits and Diversity

Modulatory Subunit Families

The Kv channel modulatory subfamily G includes multiple members[@kramer2000][@murakoshi1999]:

Functional Implications

The diversity of Kv channel modulatory subunits allows fine-tuning of neuronal excitability in different brain regions and cell types[@kramer2000][@murakoshi1999]:

Region-specific expression: Different subunits are expressed in different brain regions
Activity-dependent regulation: Expression can be modulated by neuronal activity
Pathology-responsive: Disease states alter subunit expression patterns[@kramer2000][@murakoshi1999]

Therapeutic Implications

Drug Development

Kv channels are attractive drug targets for neurodegeneration[@rudy2001][@barrese2018][@kuo2005]:

Kv2.1 modulators: Targeting Kv2.1/Kv6.1 complexes
Neuroprotective compounds: K+ channel openers for neuroprotection
Anti-excitotoxic strategies: Modulating hyperexcitability
Disease-modifying approaches: Targeting channel dysregulation[@rudy2001][@barrese2018]

Drug Classes Under Investigation

Kv channel openers: Retigabine and analogs for neuroprotection

Kv channel blockers: For reducing hyperexcitability

Subunit-selective compounds: Targeting specific Kv6.x subunits

Allosteric modulators: Binding sites distinct from traditional drugs[@rudy2001][@barrese2018]

Current Research Directions

Channel-targeted compounds: Developing subtype-selective Kv channel modulators

Gene therapy approaches: Modulating KCNG1 expression

Stem cell models: Using patient-derived neurons to study Kv channel function

Biomarkers: Kv channel dysfunction as a biomarker for neurodegeneration[@rudy2001][@kuo2005]

Genetics and Variants

While KCNG1 is not a major disease-causing gene, variant associations have been reported[@murakoshi1999][@rudy2001]:

Rare variants: Some rare KCNG1 variants have been associated with epilepsy
Expression studies: Altered KCNG1 expression in various disease states
Polymorphisms: Genetic variants may modify disease risk or progression

Genetic Studies

Genome-wide association studies: KCNG1 variants in neurological phenotypes
Expression quantitative trait loci: Disease-associated expression changes
Rare variant analysis: Exome sequencing in channelopathy cohorts[@murakoshi1999][@rudy2001]

Animal Models

Knockout mice: KCNG1 knockout mice show altered Kv channel function
Transgenic models: Expressing mutant KCNG1 variants
Disease models: KCNG1 expression changes in AD, PD, and ALS models[@kramer2000][@murakoshi1999]

Electrophysiological Studies

Patch-clamp recordings: Characterizing Kv currents in model systems
In vivo recordings: Studying neuronal firing patterns
Behavior analysis: Relating channel function to behavioral phenotypes[@kramer2000][@murakoshi1999]

Kv Channels in Disease States

Channelopathies

Although KCNG1 is not a primary channelopathy gene, Kv channel dysfunction is observed in multiple neurological conditions[@murakoshi1999][@rudy2001][@barrese2018]:

Epilepsy: Altered Kv channel expression and function
Migraine: Cortical spreading depression involves Kv channels
Ataxia: Cerebellar Kv channel dysfunction
Neuropathic pain: Peripheral Kv channel alterations[@murakoshi1999][@rudy2001]

Neurodegeneration Specific Findings

Cross-Linked Pathways

[Voltage-gated potassium channels](/mechanisms/voltage-gated-potassium-channels)
[Neuronal excitability](/mechanisms/neuronal-excitability)
[Amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Parkinson's disease](/diseases/parkinsons-disease)
[Alzheimer's disease](/diseases/alzheimers-disease)
[Excitotoxicity](/mechanisms/excitotoxicity)
[Synaptic plasticity](/mechanisms/synaptic-plasticity)

External Links

[Ensembl: ENSG00000001751](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000001751)

References

[Kramer PL, et al, Modulatory subunits of voltage-gated potassium channels (2000)](https://pubmed.ncbi.nlm.nih.gov/10722689/)

[Murakoshi H, Trimmer JS, Identification of the Kv2.1 channel as a major component of the delayed rectifier K+ current in hippocampal neurons (1999)](https://pubmed.ncbi.nlm.nih.gov/10024343/)

[Rudy B, McBain CJ, Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing (2001)](https://pubmed.ncbi.nlm.nih.gov/11506885/)

[Ye H, et al, Amyloid beta-induced alterations in neuronal excitability and potassium channel function (2019)](https://pubmed.ncbi.nlm.nih.gov/31162778/)

[Barrese V, et al, Neuronal potassium channels in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/30002537/)

[Kuo JJ, et al, Hyperexcitability and altered potassium channel expression in ALS motor neurons (2005)](https://pubmed.ncbi.nlm.nih.gov/16054197/)

[Yu SP, Regulation of neuronal death by K+ channels (2003)](https://pubmed.ncbi.nlm.nih.gov/14762899/)

📖 View canonical wiki page →

Related Entities

KCNG1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-kcng1
kg_node_id	KCNG1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1aa1d623ed2e
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-kcng1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

6

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

KCNG1 Gene

KCNG1 Gene

Overview

KCNG1 Gene

Overview

Gene Information

Protein Structure and Function

Kv Channel Architecture

Kv6.1 Structure

Modulatory Mechanisms

Expression Pattern

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Ischemia and Stroke

Molecular Mechanisms

Neuronal Excitability Regulation

Metabolic Stress Response

Synaptic Plasticity

Kv Channel Subunits and Diversity

Modulatory Subunit Families

Functional Implications

Therapeutic Implications

Drug Development

Drug Classes Under Investigation

Current Research Directions

Genetics and Variants

Genetic Studies

Animal Models

Electrophysiological Studies

Kv Channels in Disease States

Channelopathies

Neurodegeneration Specific Findings

Cross-Linked Pathways

See Also

External Links

References

💬 Discussion